Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.24.2.u1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenue
Operating expenses        
Research and development 2,307,873 1,379,567 4,502,386 3,207,474
General and administrative 353,531 368,259 696,219 781,434
Total operating expenses 2,661,404 1,747,826 5,198,605 3,988,908
Loss from operations (2,661,404) (1,747,826) (5,198,605) (3,988,908)
Interest Income 54,722 119,453 118,728 235,633
Net loss $ (2,606,682) $ (1,628,373) $ (5,079,877) $ (3,753,275)
Per share information:        
Net loss per common share, basic $ (0.20) $ (0.13) $ (0.39) $ (0.29)
Net loss per common share, diluted $ (0.20) $ (0.13) $ (0.39) $ (0.29)
Weighted average common shares outstanding, basic 12,906,867 12,848,165 12,882,896 12,848,165
Weighted average common shares outstanding, diluted 12,906,867 12,848,165 12,882,896 12,848,165